Viable cryopreserving tissue-engineered cell-biomaterial for cell banking therapy in an effective cryoprotectant

Tissue Engineering - Part C: Methods

Volumn 17, Issue 8, 2011, Pages 799-807

  Umemura, Eri ^a   Yamada, Yoichi ^a   Nakamura, Sayaka ^a   Ito, Kenji ^b   Hara, Kenji ^b   Ueda, Minoru ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Hamamatsu Kita Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MATERIALS PRESERVATION; BIOMATERIALS; CALCIUM CARBONATE; COAGULATION; DRUG DELIVERY; DRUG PRODUCTS; ETHYLENE; ETHYLENE GLYCOL; GELATION; GELS; OPTIMIZATION; PATIENT TREATMENT; SCANNING ELECTRON MICROSCOPY; STEM CELLS; SUGAR (SUCROSE); TISSUE; TISSUE ENGINEERING;

CELL BANKING; CELL VIABILITY; CRYO-PRESERVATION; CRYOPROTECTANTS; DENTAL PULP; DRUG DELIVERY SYSTEM; FLOW-CYTOMETRIC ANALYSIS; OPTIMALITY; POLYVINYL PYRROLIDONE; REGENERATIVE MEDICINE; TISSUE-ENGINEERED CONSTRUCTS;

CYTOLOGY;

BIOMATERIAL; CRYOPROTECTIVE AGENT; POLYSACCHARIDE; POVIDONE;

ARTICLE; CELL SURVIVAL; CHEMICAL MODEL; CHEMISTRY; CRYOPRESERVATION; CULTURE TECHNIQUE; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; GEL; HUMAN; INSTRUMENTATION; METHODOLOGY; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING;

BIOCOMPATIBLE MATERIALS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; GELS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MODELS, CHEMICAL; POLYSACCHARIDES; POVIDONE; TISSUE ENGINEERING;

EID: 79961069490     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2011.0003     Document Type: Article

References (25)

1. Langer, R., and Vacanti, J.P. Tissue engineering. Science 260, 920, 1993.
2. Khademhosseini, A., Langer, R., Borenstein, J., and Vacanti, J.P. Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci USA 103, 2480, 2006.
3. Levenberg, S., Huang, N.F., Lavik, E., Rogers, A.B., Itskovitz-Eldor, J., and Langer, R. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci USA 100, 12741, 2003.
4. Hunt, N.C., Shelton, R.M., and Grover, L.M. Reversible mitotic and metabolic inhibition following the encapsulation of fibroblasts in alginate hydrogels. Biomaterials 30, 6435, 2009.
5. Yamada, Y., Ueda, M., Naiki, T., Takahashi, M., Hata, K., and Nagasaka, T. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration. Tissue Eng 10, 955, 2004.
6. Zimmermann, H., Ehrhart, F., Zimmermann, D., Muller, K., Katsen-Globa, A., Behringer, M., Feilen, P.J., Gessner, P., Zimmermann, G., Shirley, S.G., Weber, M.M., Metze, J., and Zimmermann, U. Hydrogel-based encapsulation of biological, functional tissue: fundamentals, technologies and applications. Appl Phys Mater Sci Process 89, 909, 2007.
7. Bhakta, G., Lee, K.H., Magalhaes, R., Wen, F., Gouk, S.S., Hutmacher, D.W., and Kuleshova, L.L. Cryopreservation of alginate-fibrin beads involving bone marrow derived mesenchymal stromal cells by vitrification. Biomaterials 30, 336, 2009.
8. Matsumoto, Y., Morinaga, Y., Ujihara, M., Oka, K., and Tanishita, K. Improvement in the viability of cryopreserved cells by microencapsulation JSME. Int J C Mech Syst Machine Elem Manuf 44, 937, 2001.
9. Hunt, N.C., and Grover, L.M. Cell encapsulation using biopolymer gels for regenerative medicine. Biotechnol Lett 32, 733, 2010.
10. Kuleshova, L.L., Gouk, S.S., and Hutmacher, D.W. Vitrification as a prospect for cryopreservation of tissueengineered constructs. Biomaterials 28, 1585, 2007.
11. Mukaida, T., Wada, S., Takahashi, K., Pedro, P.B., An, T.Z., and Kasai, M. Vitrification of human embryos based on the assessment of suitable conditions for 8-cell mouse embryos. Hum Reprod 13, 2874, 1998.
12. Baust, J.M., Van Buskirk, R., and Baust, J.G. Modulation of the cryopreservation cap: elevated survival with reduced dimethyl sulfoxide concentration. Cryobiology 45, 97, 2002.
13. Sugiyama, N., Mizuguchi, T., Aoki, T., Hui, T., Inderbitzin, D., Demetriou, A.A., and Rozga, J. Glycerol suppresses proliferation of rat hepatocytes and human HepG2 cells. J Surg Res 103, 236, 2002.
14. Hubalek, Z. Protectants used in the cryopreservation of microorganisms. Cryobiology 46, 205, 2003.
15. Gronthos, S., Mankani, M., Brahim, J., Robey, P.G., and Shi, S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 97, 13625, 2000.
16. Gronthos, S., Brahim, J., Li, W., Fisher, L.W., Cherman, N., Boyde, A., DenBesten, P., Robey, P.G., and Shi, S. Stem cell properties of human dental pulp stem cells. J Dent Res 81, 531, 2002.
17. Nakamura, S., Yamada, Y., Katagiri, W., Sugito, T., Ito, K., and Ueda, M. Stem cell proliferation pathways comparison between human exfoliated deciduous teeth and dental pulp stem cells by gene expression profile from promising dental pulp. J Endod 35, 1536, 2009.
18. Yamada, Y., Fujimoto, A., Ito, A., Yoshimi, R., and Ueda, M. Cluster analysis and gene expression profiles: a cDNA microarray system-based comparison between human dental pulp stem cells (hDPSCs) and human mesenchymal stem cells (hMSCs) for tissue engineering cell therapy. Biomaterials 27, 3766, 2006.
19. Kuo, C.K., and Ma, P.X. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: part 1. Structure, gelation rate and mechanical properties. Biomaterials 22, 511, 2001.
20. Yamada, Y., Nakamura, S., Ito, K., Sugito, T., Yoshimi, R., Nagasaka, T., and Ueda, M. A feasibility of useful cell-based therapy by bone regeneration with deciduous tooth stem cells, dental pulp stem cells, or bone marrow-derived mesenchymal stem cells for clinical study using tissue engineering technology. Tissue Eng 16, 1891, 2010.
21. Vanhoutte, L., Cortvrindt, R., Nogueira, D., and Smitz, J. Effects of chilling on structural aspects of early preantral mouse follicles. Biol Reprod 70, 1041, 2004.
22. Kuleshova, L.L., MacFarlane, D.R., Trounson, A.O., and Shaw, J.M. Sugars exert a major influence on the vitrification properties of ethylene glycol-based solutions and have low toxicity to embryos and oocytes. Cryobiology 38, 119, 1999.
23. Keros, V., Xella, S., Hultenby, K., Pettersson, K., Sheikhi, M., Volpe, A., Hreinsson, J., and Hovatta, O. Vitrification versus controlled-rate freezing in cryopreservation of human ovarian tissue. Hum Reprod 24, 1670, 2009.
24. Shaw, J.M., Kuleshova, L.L., MacFarlane, D.R., and Trounson, A.O. Vitrification properties of solutions of ethylene glycol in saline containing PVP, Ficoll, or dextran. Cryobiology 35, 219, 1997.
25. L'Heureux, N., Dusserre, N., Konig, G., Victor, B., Keire, P., Wight, T.N., Chronos, N.A., Kyles, A.E., Gregory, C.R., Hoyt, G., Robbins, R.C., and McAllister, T.N. Human tissueengineered blood vessels for adult arterial revascularization. Nat Med 12, 361, 2006.